← Evidence map

ReviewCureus2023

Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics.

Abdelrahman Abaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37667784